نتائج البحث

New warning about ADHD drug.

Subjects: Chemical and Drug Induced Liver Injury*; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Propylamines/Propylamines/Propylamines/*adverse effects

• Source: FDA consumer [FDA Consum] 2005 Mar-Apr; Vol. 39 (2), pp. 3.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

FDA approves new drug for treatment of erectile dysfunction in men.

Subjects: Drug Approval*; Erectile Dysfunction/Erectile Dysfunction/Erectile Dysfunction/*drug therapy ; Imidazoles/Imidazoles/Imidazoles/*therapeutic use

• Source: FDA consumer [FDA Consum] 2003 Sep-Oct; Vol. 37 (5), pp. 7.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Labeling changes for arthritis drug.

Subjects: Drug Labeling*; Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*adverse effects ; Arthritis/Arthritis/Arthritis/*drug therapy

• Source: FDA consumer [FDA Consum] 2002 Sep-Oct; Vol. 36 (5), pp. 6.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

New schizophrenia drug.

Subjects: Drug Approval*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Piperazines/Piperazines/Piperazines/*therapeutic use

• Source: FDA consumer [FDA Consum] 2001 May-Jun; Vol. 35 (3), pp. 6.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

New drug fights invasive fungal infection.

Subjects: Drug Approval* ; Peptides* ; Peptides, Cyclic*

• Source: FDA consumer [FDA Consum] 2001 May-Jun; Vol. 35 (3), pp. 5.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Foreign drug firm pleads guilty to felony charges.

• Authors : Lewis C

Subjects: Drug Compounding* ; Drug Industry*; Cefaclor/Cefaclor/Cefaclor/*chemistry

• Source: FDA consumer [FDA Consum] 2002 Jan-Feb; Vol. 36 (1), pp. 35.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Serious liver injury. Leading reason for drug removals, restrictions.

• Authors : Meadows M

Subjects: Drug Approval* ; Fluoroquinolones* ; Product Surveillance, Postmarketing*

• Source: FDA consumer [FDA Consum] 2001 May-Jun; Vol. 35 (3), pp. 8-9.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Labeling changes for asthma drug salmeterol.

Subjects: Drug Labeling*; Adrenergic beta-Agonists/Adrenergic beta-Agonists/Adrenergic beta-Agonists/*adverse effects ; Albuterol/Albuterol/Albuterol/*adverse effects

• Source: FDA consumer [FDA Consum] 2003 Nov-Dec; Vol. 37 (6), pp. 6.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Drug research and children.

• Authors : Meadows M

Subjects: Drug Therapy* ; Research*; Child

• Source: FDA consumer [FDA Consum] 2003 Jan-Feb; Vol. 37 (1), pp. 12-7.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

When is a medical product too risky? An interview with FDA's top drug official. Interview by Tamar Nordenberg.

• Authors : Woodcock J

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/organization & administration ; Drug Approval*/Drug Approval*/Drug Approval*/statistics & numerical data ; Drug-Related Side Effects and Adverse Reactions*

• Source: FDA consumer [FDA Consum] 1999 Sep-Oct; Vol. 33 (5), pp. 8-11, 13.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان